Assessment of apoptosis in relation to single cytogenetic abnormalities in myelodysplastic syndromes (MDS).

被引：0

作者：

Mundle, S ^{[1
]}

Hsu, WT ^{[1
]}

Dutt, D ^{[1
]}

Dar, S ^{[1
]}

Saberwal, G ^{[1
]}

Townsend, W ^{[1
]}

Broderick, E ^{[1
]}

Kaspar, C ^{[1
]}

Alvi, S ^{[1
]}

Shetty, V ^{[1
]}

Allampallam, K ^{[1
]}

Reddy, P ^{[1
]}

Venugopal, P ^{[1
]}

Gezer, S ^{[1
]}

Lisak, L ^{[1
]}

Raza, A ^{[1
]}

机构：

[1] Rush Canc Inst, MDS Ctr, Chicago, IL USA

来源：

BLOOD | 2001年 / 98卷 / 11期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

4464

引用

页码：191B / 191B

页数：1

共 50 条

[1] Cytogenetic changes in myelodysplastic syndromes (MDS)
Haus, O
Kotlarek-Haus, S
Czarnecka, M
Potoczek, S
Kyrcz-Krzemien, S
Duszenko, E
Makowska, I
CYTOGENETICS AND CELL GENETICS, 1999, 85 (1-2): : 71 - 71
[2] Cytogenetic abnormalities at diagnosis are the most important prognostic factor in the myelodysplastic syndromes (MDS)
Buckstein, R
Crump, M
Imrie, K
Sutton, D
Pantalony, D
Sher, G
Stewart, AK
Keating, A
BLOOD, 1996, 88 (10) : 2317 - 2317
[3] DISTRIBUTION OF CYTOGENETIC ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES IN A SINGLE CENTER IN ALGERIA
Souad, T.
Yamina, B.
Tayeb, A. M.
HAEMATOLOGICA, 2014, 99 : 611 - 611
[4] Rare Cytogenetic Abnormalities in Myelodysplastic Syndromes
Bacher, Ulrike
Schanz, Julie
Braulke, Friederike
Haase, Detlef
MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2015, 7
[5] CYTOGENETIC STUDIES IN 69 PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS)
WEH, HJ
CALAVREZOS, A
SEEGER, D
KUSE, R
HOSSFELD, DK
EUROPEAN JOURNAL OF HAEMATOLOGY, 1987, 38 (02) : 166 - 172
[6] THE PROGNOSTIC-SIGNIFICANCE OF CYTOGENETIC ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES (MDS) FOLLOWING G-CSF
LEBEAU, M
TAYLOR, K
LARSON, R
KOEFFLER, P
NEGRIN, R
SABA, H
GANSER, A
JAKUBOWSKI, A
GABRILOVE, J
MUFTI, GJ
CRUZ, J
LANGLEY, G
VARDIMAN, J
DAVIS, M
GREENBERG, P
BLOOD, 1993, 82 (10) : A375 - A375
[7] Impact of Cytogenetic Abnormalities and Cytogenetic Response to Hypomethylating Agents (HMAs) in Patients (pts) with Lower Risk Myelodysplastic Syndromes (MDS)
Montalban-Bravo, Guillermo
Carcia-Manero, Guillermo
Short, Nicholas J.
Sasaki, Koji
Sekeres, Mikkael A.
Komrokji, Rami S.
Steensma, David P.
DeZern, Amy E.
Roboz, Gail J.
Kadia, Tapan
Borthakur, Gautam
DiNardo, Courtney
Miller, Darla
Estrov, Zeev
Pemmaraju, Naveen
Daver, Naval
Konopleva, Marina
Cortes, Jorge E.
Kantarjian, Hagop M.
Jabbour, Elias
BLOOD, 2015, 126 (23)
[8] RISK ASSESSMENT IN MYELODYSPLASTIC SYNDROMES (MDS)
Improta, S.
Gagliardi, A.
Lucania, A.
Della Cioppa, P.
Villa, M. R.
Esposito, M.
Quirino, A.
Mastrullo, L.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 556 - 557
[9] Distribution of cytogenetic abnormalities in myelodysplastic syndromes, Philadelphia negative myeloproliferative neoplasms, and the overlap MDS/MPN category
Bacher, Ulrike
Schnittger, Susanne
Kern, Wolfgang
Weiss, Tamara
Haferlach, Torsten
Haferlach, Claudia
ANNALS OF HEMATOLOGY, 2009, 88 (12) : 1207 - 1213
[10] Distribution of cytogenetic abnormalities in myelodysplastic syndromes, Philadelphia negative myeloproliferative neoplasms, and the overlap MDS/MPN category
Ulrike Bacher
Susanne Schnittger
Wolfgang Kern
Tamara Weiss
Torsten Haferlach
Claudia Haferlach
Annals of Hematology, 2009, 88 : 1207 - 1213

← 1 2 3 4 5 →